AKAP9 Gene Long QT Syndrome Type 11 Genetic Test
At DNA Labs UAE, we offer the AKAP9 Gene Long QT syndrome type 11 Genetic Test. This test is designed to analyze the AKAP9 gene, which is associated with Long QT syndrome type 11. Long QT syndrome is a genetic disorder that affects the electrical system of the heart, potentially causing abnormal heart rhythms, fainting, seizures, or sudden cardiac arrest.
Test Components and Price
The AKAP9 Gene Long QT syndrome type 11 Genetic Test is priced at 4400.0 AED. The test requires a blood sample for analysis.
Report Delivery and Method
The report for the AKAP9 Gene Long QT syndrome type 11 Genetic Test will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes to identify genetic variations or mutations associated with a specific condition or disease.
Test Type and Doctor
The AKAP9 Gene Long QT syndrome type 11 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. The test is conducted by a cardiologist in our Genetics department.
Pre-Test Information
Prior to undergoing the AKAP9 Gene Long QT syndrome type 11 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the AKAP9 Gene Long QT syndrome type 11 NGS Genetic DNA Test gene AKAP9. This information is crucial in understanding the inheritance pattern and assessing the risk for the condition.
Test Details
The AKAP9 gene is associated with Long QT syndrome type 11. By conducting an NGS genetic test, we can analyze the AKAP9 gene for any potential mutations or variations that may be causing the condition. This test is not only useful in diagnosing individuals with Long QT syndrome type 11 but also in identifying carriers of the gene mutation who may be at risk of passing the condition on to their children. The results of this test provide valuable information for genetic counseling and treatment decisions.
Test Name | AKAP9 Gene Long QT syndrome type 11 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AKAP9 Gene Long QT syndrome type 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AKAP9 Gene Long QT syndrome type 11 NGS Genetic DNA Test gene AKAP9 |
Test Details |
The AKAP9 gene is associated with Long QT syndrome type 11, which is a genetic disorder that affects the electrical system of the heart. Long QT syndrome can cause abnormal heart rhythms, which can lead to fainting, seizures, or sudden cardiac arrest. NGS (Next-Generation Sequencing) Genetic Test is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition or disease. In the case of Long QT syndrome type 11, an NGS genetic test can be used to analyze the AKAP9 gene for any potential mutations or variations that may be causing the condition. This type of genetic test can help in diagnosing individuals with Long QT syndrome type 11, as well as identifying carriers of the gene mutation who may be at risk of passing the condition on to their children. It can also provide valuable information for genetic counseling and treatment decisions. |